Nabil Saba, MD
Enriched profileProfessor and Vice Chair for Quality and Safety, Department of Hematology and Medical Oncology; Director, Head and Neck Cancer Multidisciplinary Program; Inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research · Emory University School of Medicine
Nabil Saba is Professor and Vice Chair for Quality and Safety, Department of Hematology and Medical Oncology; Director, Head and Neck Cancer Multidisciplinary Program; Inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research at Emory University School of Medicine. OpenAlex indexes 869 publications with 22,402 citations (h-index 62); ClinicalTrials.gov lists 15 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 13 Oct 2026
Nabil Saba, MD, is Professor and Vice Chair for Quality and Safety, Department of Hematology and Medical Oncology at Emory University School of Medicine / Winship Cancer Institute. The public record shows 869 publications with 22,402 citations (h-index 62), centered on Gastroesophageal Cancer, Head & Neck Cancer. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 27 companies, 3 NIH-funded awards (2014–2026).
- Most recent indexed publication: 2026 · Head & neck
- Top research focus: Gastroesophageal Cancer
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 101 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 13 Oct 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Dr.Reddy's Laboratories,Inc.Program year20258 payments$29,298openpaymentsdata.cms.gov ↗
- Exelixis Inc.Program year202515 payments$25,985openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202511 payments$11,106openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.1%Kinase inhibitor30.1%Mekinist28%Tafinlar28%Lenvima15%Cabometyx13%Verzenio10%Caprelsa6%Part D<11 patientsMetabolism & gastrointestinal
25.3%Serotonin-3 Receptor Antagonist19.2%Ondansetron Hcl86%Ondansetron Odt14%Part D<11 patientsCorticosteroid3.5%Prednisone100%Part D≥11 patients+ 1 more class in this area
Nervous system
18.3%Phenothiazine13.7%Prochlorperazine Maleate100%Part D≥45 patientsOpioid Agonist4.6%Oxycodone Hcl57%Oxycodone-Acetaminophen43%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Oct 2026
3 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- Winship National Clinical Trials Network Lead Academic Participating Site
Emory University
FY2026$920,141UG1CA233247 - Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients
Emory University
FY2026$397,537U01DC020452 - Winship National Clinical Trials Network Lead Academic Participating Site
Emory University
FY2025$682,746UG1CA233247
Publications
Updated 13 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review.
Journal of the National Cancer Institute
Review2026 - GLS1 Orchestrates Exosome-Mediated Tumor-Endothelial Communication to Facilitate Angiogenesis.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Article2026
Online presence
Updated 13 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nabil-saba-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/drnabilsaba
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Nabil-Saba
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/drnabilsaba
Mentions by others
where others cite or feature them- Other
ahns.info/public-profiles/nabil-saba-atlanta-ga
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ahns.info ↗ - Other
onclive.com/authors/nabil-f-saba-md-facp-emory-university
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Other
vjoncology.com/speaker/nabil-saba
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjoncology.com ↗ - X / Twitter
x.com/NRGonc/status/2010736109102190773
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - Ahns.info
American Head & Neck Society public profile page (Atlanta, GA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ahns.info ↗ - Doximity
Doximity physician profile
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- B.S. in Chemistry
American University of Beirut
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - FACP
Fellow of the American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org ↗
Editorial & leadership roles
journal and society appointments- Director
Head and Neck Cancer Medical Oncology Program, Winship Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - Co-director/Leader
Head and Neck Cancer Multidisciplinary Program, Winship Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - Co-chair
NCI Head and Neck Cancer Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - Contact Principal Investigator
NCI National Clinical Trials Network Lead Academic Participating Site grant (Emory)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- Director of house staff education program
Winship Cancer Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- Inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research
Winship Cancer Institute
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor
Department of Otolaryngology, Emory University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
Media & interviews
press, podcasts and appearances- Recurring on-camera interview speaker for VJOncology (The Video Journal of Oncology)
discussing head and neck cancer immunotherapy and treatment advances
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjoncology.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apps.winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apps.winshipcancer.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apps.winshipcancer.emory.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Guy McKhann, MD
Emory University School of Medicine
Arshed Quyyumi, MD
Emory University School of Medicine
Guillermo Umpierrez, MD
Emory University School of Medicine
Stewart Factor, DO
Emory University School of Medicine
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH